Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records
Authors Williams NP, Coombs NA, Johnson MJ, Josephs LK, Rigge LA, Staples KJ, Thomas M, Wilkinson TMA
Received 3 September 2016
Accepted for publication 21 November 2016
Published 17 January 2017 Volume 2017:12 Pages 313—322
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Richard Russell
Nicholas P Williams,1,2 Ngaire A Coombs,3 Matthew J Johnson,4 Lynn K Josephs,3,4 Lucy A Rigge,2,4 Karl J Staples,2 Mike Thomas,1,3,4 Tom MA Wilkinson1,2,4
1Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, 2Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, 3Primary Care and Population Sciences, Faculty of Medicine, Southampton General Hospital, 4NIHR CLAHRC Wessex, Faculty of Health Sciences, University of Southampton, Southampton General Hospital, Southampton, UK
Background: Community-acquired pneumonia (CAP) is more common in patients with COPD than in the adult general population, with studies of hospitalized CAP patients consistently reporting COPD as a frequent comorbidity. However, despite an increasing recognition of its importance, large studies evaluating the incidence patterns over time, risk factors and burden of CAP in COPD are currently lacking.
Methods: A retrospective observational study using a large UK-based database of linked primary and secondary care records was conducted. Patients with a diagnosis of COPD aged ≥40 years were followed up for 5 years from January 1, 2010. CAP and exacerbation episodes were identified from hospital discharge data and primary care coding records, and rates were calculated per month, adjusting for mortality, and displayed over time. In addition, baseline factors predicting future risk of CAP and hospital admission with CAP were identified.
Results: A total of 14,513 COPD patients were identified: 13.4% (n=1,938) had ≥1 CAP episode, of whom 18.8% suffered from recurrent (≥2) CAP. Highest rates of both CAP and exacerbations were seen in winter. A greater proportion of frequent, compared to infrequent, exacerbators experienced recurrent CAP (5.1% versus 2.0%, respectively, P<0.001); 75.6% of CAP episodes were associated with hospital admission compared to 22.1% of exacerbations. Older age and increasing grade of airflow limitation were independently associated with increased odds of CAP and hospital admission with CAP. Other independent predictors of future CAP included lower body mass index, inhaled corticosteroid use, prior frequent exacerbations and comorbidities, including ischemic heart disease and diabetes.
Conclusion: CAP in COPD demonstrates clear seasonal patterns, with patient characteristics predictive of the odds of future CAP and hospital admission with CAP. Highlighting this burden of COPD-associated CAP during the winter period informs us of the likely triggers and the need for more effective preventive strategies.
Keywords: COPD exacerbations, exacerbation frequency, community-acquired pneumonia, comorbidity
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]